U.S. officials hopeful as advisers meet again on J&J COVID-19 vaccine

Advisers to the U.S. Centers for Disease Control and Prevention will meet again on Friday to consider whether it is safe to resume injections of Johnson & Johnson’s COVID-19 vaccine, as senior U.S. health officials prepare for a green light.

The panel last week called for more data about a possible link to rare blood clots in the brain before deciding how and whether to end a "pause" in administration of J&J vaccines called for by the CDC and the Food and Drug Administration.

The decision by CDC's advisory panel...